Ayala Pharmaceuticals Inc (ADXS)

[jckrdu]

"With each passing month the hope for a deal fades as well as the cash in the coffers"

_____________________________________

Disagree. No one likes the current pps, but it's not all doom and gloom.

On deal prospects - With each passing day, the likelihood of a deal increases, not decreases. AXAL conditional approval has been submitted with a response expected from the EMA in less than 12 months. I'm sure Advaxis wants to have the commercialization partnership executed in advance of the EMA decision, so they can hit the ground running after the expected approval. It's in both Advaxis' and the potential future partner's interest to get a deal done now, so revenue can be generated as soon as possible after approval.

On cash - The $2 offering was likely done because Lombardo & the BOD didn't like the AXAL deals that were on the table at that time. Raising at $2 was bad, but it got them cash runway into 2nd QTR 2019, which is 1 QTR past the expected EMA decision. That's what Bonesteel's article was talking about, IMO. Additional cash runway past 2nd QTR 2019 available/coming via 1) Cantor ATM, and 2) NEO dosing cash milestone. May see an offering AFTER AXAL deal is announced, at a higher pps, IMO.